Zydus Wellness Limited has disclosed multiple equity share acquisitions by designated persons under the SEBI (Prohibition of Insider Trading) Regulations, 2015. Three designated persons - Mr. Vineet Shrivastava, Mr. Yatin Desai, and Mr. Rajat Bhargava - acquired a total of 2,037 equity shares from the open market between March 2-6, 2026.

Transaction Overview

The share acquisitions were executed on NSE with specific financial parameters outlined in the regulatory disclosures. The transactions represent a combined investment of ₹7,77,935.55 by the three designated persons, with each equity share having a face value of ₹2/-.

Individual Shareholding Impact

The transactions show varying impacts on individual shareholding positions. Mr. Vineet Shrivastava increased his holdings from 507 shares to 1,294 shares, while Mr. Yatin Desai's holdings grew from 25 shares to 525 shares. Mr. Rajat Bhargava acquired his first equity position in the company with 750 shares.

Regulatory Compliance

The disclosures were made in accordance with Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. Zydus Wellness Limited submitted the prescribed Form "B" to both BSE Limited and National Stock Exchange of India Limited on March 9, 2026. The company secretary and compliance officer, Nandish P. Joshi, signed the disclosure document digitally.

Designated Persons Profile

All three designated persons are associated with Zydus Wellness Limited's organizational structure and are based at the company's corporate office at Zydus Corporate Park, Scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, S. G. Highway, Ahmedabad – 382481, Gujarat. The disclosures confirm that no derivative trading activities were undertaken by any of the designated persons in connection with these transactions, as indicated by the "N.A." entries in the derivatives trading sections of the regulatory forms.

Zydus Wellness Limited has disclosed that its Chief Financial Officer Umesh V. Parikh acquired 250 equity shares of the company from the open market on March 2, 2026. The transaction was disclosed under SEBI (Prohibition of Insider Trading) Regulations, 2015, as required for designated persons of listed companies.

Transaction Details

The share acquisition involved 250 equity shares of ₹2/- each, purchased at a total value of ₹95,019.00 through open market transactions on BSE. This transaction increased Parikh's total shareholding in Zydus Wellness from 18,755 shares to 19,005 shares.

Shareholding Position

Following the acquisition, Parikh's shareholding position in Zydus Wellness has been updated. His total holding increased from 18,755 shares to 19,005 shares, though the percentage shareholding remains at 0.00% as disclosed in the regulatory filing.

Regulatory Compliance

Zydus Wellness filed the disclosure on March 3, 2026, in prescribed Form B under Regulation 7(2) of SEBI PIT Regulations, 2015. The disclosure was signed by Company Secretary and Compliance Officer Nandish P. Joshi and submitted to both BSE Limited and National Stock Exchange of India Limited.

The filing confirms that no derivative trading was involved in this transaction, with all derivative-related fields marked as "N.A." in the regulatory form. This acquisition represents a routine compliance disclosure for insider trading regulations applicable to designated persons of listed companies.